A Randomized Parallel Comparison of Semaglutide Versus Placebo on Intestinal Barrier Function in Type 2 Diabetes Mellitus (SIB)
Latest Information Update: 15 Jun 2023
Price :
$35 *
At a glance
- Drugs Semaglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms SIB
- 25 Jan 2022 Status changed from not yet recruiting to recruiting.
- 23 Nov 2021 Planned initiation date changed from 1 Nov 2021 to 15 Dec 2021.
- 27 Sep 2021 Planned initiation date changed from 1 Sep 2021 to 1 Nov 2021.